Sumitomo Corporation announced on May 1 that it will transfer 50 per cent of its equity interest in Van Phong Power Co., Ltd.

With over $20 billion in expected investment over the coming years, Can Gio district is becoming a new magnet for capital ...

Trinh Ha, senior analyst at Exness Investment Bank, talked with VIR’s Thy Nguyet about Vietnam’s positioning in global supply ...

Vietnam is moving closer to legalising digital asset transactions, marking a significant step that could unlock substantial ...

At a conference with small and medium-sized enterprises in early 2025, Prime Minister Pham Minh Chinh tasked the Ministry of ...

ADB director outlines bold strategies to transform Asia’s agri-food systems to secure a sustainable, inclusive, and resilient ...

Following the strong recovery in 2024, F88 continues to fare well in the first quarter of 2025 with significant improvements ...

In partnership with the Australian Government, Endeavour Energy is deploying the largest community battery program in NSW and ...

Backed by catalytic capital, Co-Axis is set to transform climate and health solutions where they’re needed most.

Global AT2R-targeted drug development remains nascent, with only a few competitors like Lilly-partnered CFTX-1554 (Phase I).

A potential game changer in the treatment of retinal disease, the novel dual-target drug shows encouraging results.